Radisens Diagnostics

About Radisens Diagnostics

Radisens Diagnostics is a company focused on developing advanced diagnostic tools for the healthcare sector. Specifically, Radisens is creating a high-sensitivity, quantitative, point-of-care diagnostic platform designed to measure Ferritin iron stores in blood donors who are at risk. Ferritin is a protein that stores iron in the body, and its measurement is crucial for ensuring the safety and health of blood donors.

The company operates in the in vitro diagnostics market, which involves tests done on samples such as blood or tissue that are taken from the human body. Radisens' technology is intended for professional use only and is designed to provide quick and accurate results directly at the point of care, meaning the location where the patient is receiving care, such as a clinic or hospital.

Radisens' business model is business-to-business (B2B). They aim to form strategic partnerships with other companies for technology licensing, manufacturing, and distribution. These partnerships are essential for bringing their diagnostic platform to market and ensuring it reaches healthcare providers who can use it to monitor Ferritin levels in blood donors.

The company generates revenue through these partnerships, as well as through the sale and licensing of their diagnostic technology. By focusing on a niche but critical area of healthcare diagnostics, Radisens aims to address a significant need in the blood donation process, ensuring that donors are healthy and that the blood supply is safe.

In summary, Radisens Diagnostics is a specialized healthcare technology company developing point-of-care diagnostic tools to measure Ferritin iron stores in blood donors. They operate in the in vitro diagnostics market and rely on strategic B2B partnerships for revenue.